Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclooxygenase-2 (Cox-2) expression in lymphomas.

Burhan Hazar1, Melek Ergin, Ertuğrul Seyrek

  • 1Mersin University Medical Faculty, Department of Oncology, Mersin, Turkey. hazarburhan@hotmail.com

Leukemia & Lymphoma
|September 14, 2004
PubMed
Summary

Cyclooxygenase-2 (Cox-2) expression is linked to lymphoma progression and poorer treatment response in non-Hodgkin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative analysis of acidosis defense mechanisms in preimplantation embryos in BALB/c strain mice: in vivo vs in vitro development.

Reproduction, fertility, and development·2026
Same author

MDM2 and DDIT3 coexpression in dedifferentiated liposarcoma with myxoid features: a retrospective cohort study.

Scientific reports·2026
Same author

The Correlation Between PD-L1 Expression in Metaplastic Breast Cancer and Clinical-Pathological Features and Prognosis.

Medicina (Kaunas, Lithuania)·2026
Same author

Characterizing breach rhythm in EEG: Insights into its variability and clinical impact.

Neurophysiologie clinique = Clinical neurophysiology·2026
Same author

Hashimoto's encephalopathy in psychiatric inpatients: neuropsychiatric morbidity, diagnostic challenges and treatment.

Frontiers in psychiatry·2025
Same author

Retrospective chart review of cases of steroid-responsive catatonia: exploring a potential autoimmune aetiology.

BJPsych open·2025

Area of Science:

  • Oncology
  • Immunohistochemistry
  • Molecular Biology

Background:

  • Lymphoma is a significant malignancy of the lymphoid system.
  • Cyclooxygenase-2 (Cox-2) is implicated in various cancers.
  • The role of Cox-2 in lymphoma pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the expression and clinical significance of Cyclooxygenase-2 (Cox-2) in patients with lymphoma.
  • To explore the correlation between Cox-2 expression and prognostic factors in lymphoma.

Main Methods:

  • Immunohistochemical analysis of Cox-2 expression in lymphoma tissues.
  • Correlation analysis of Cox-2 expression with patient demographics, disease stage, and treatment response.
  • Statistical evaluation of survival data and response rates.

Related Experiment Videos

Main Results:

  • Cox-2 expression was observed in 57% of non-Hodgkin's lymphoma (NHL) and 70% of Hodgkin's disease (HD) patients.
  • Increased Cox-2 expression correlated with advanced disease stage in NHL (P = 0.037).
  • Complete response rates to therapy were significantly higher in Cox-2-negative patients (70.6%) compared to Cox-2-positive patients (20.8%) in NHL (P = 0.001).

Conclusions:

  • Cox-2 expression is clinically correlated with prognostic factors in lymphoma.
  • Targeting Cox-2 may offer potential therapeutic strategies for lymphoma.
  • Further research into Cox-2 inhibitors combined with chemotherapy is warranted for lymphoma treatment.